EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Ocular TB as the only manifestation of TB: diagnostic uncertainty and treatment thresholds

Sedra T Alabed, Diana Finkel

International Ophthalmology · 19.06.2026 · 46 (1)

DOI: 10.1007/s10792-026-04134-3 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Ophthalmology, online erschienen am 19.06.2026. Verfasst von Sedra T Alabed und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Rutgers New Jersey Medical School, Newark, NJ, USA. Hauptthemen laut MEDLINE: Tuberculosis, Ocular, Antitubercular Agents. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To review diagnostic approaches and treatment thresholds for presumed tuberculous uveitis when ocular inflammation is the only manifestation of tuberculosis (TB), focusing on phenotype-based risk stratification, interferon-gamma release assay (IGRA) interpretation, mimic exclusion, and evidence for antitubercular therapy (ATT).

Methods

Narrative review using targeted PubMed search of ocular TB literature. Search terms included “ocular tuberculosis”, “tuberculous uveitis”, specific phenotypes (serpiginous-like choroiditis, retinal vasculitis, tuberculoma), and treatment outcomes. We prioritized consensus guidelines, systematic reviews, meta-analyses, and randomized data. Findings were synthesized into a phenotype-anchored diagnostic and treatment algorithm.

Results

Ocular TB is usually diagnosed through a comprehensive assessment of ocular phenotype, epidemiologic risk, systemic evaluation, TB immunologic testing, and mimic exclusion. Higher-suspicion phenotypes include serpiginous-like choroiditis, occlusive retinal vasculitis, choroidal tuberculoma, anterior uveitis with iris nodules, and chronic granulomatous anterior uveitis in the appropriate clinical context. IGRA results support prior TB sensitization but do not establish ocular causality; positive results may be incidental, particularly in low-burden settings, while negative results do not fully exclude ocular TB when phenotype and epidemiologic context are strongly suggestive. Consensus guidance and recent randomized evidence support ATT in selected patients, but treatment thresholds remain phenotype- and context-dependent.

Conclusion

Compatible ocular phenotypes should prompt TB-directed evaluation, including IGRA and systemic assessment, with immunologic testing interpreted as supportive evidence. Treatment decisions should consider phenotype, epidemiological risk, mimic exclusion, and consequences of delayed treatment. High-risk presentations may justify lower treatment thresholds, while nonspecific ocular findings with isolated immunologic positivity should prompt consideration of alternative diagnoses or LTBI management according to local guidance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tuberculosis, OcularAntitubercular AgentsHumansInterferon-gamma Release TestsDiagnosis, Differential

Stichwörter der Autor:innen

Interferon-gamma release assayLatent tuberculosis infectionOcular tuberculosisRetinal vasculitisSerpiginous-like choroiditisTuberculous uveitis

Substanzen

Antitubercular Agents

Autor:innen und Institutionen

  • Department of Infectious Diseases, Rutgers New Jersey Medical School, Newark, NJ, USA.
  • Department of Infectious Diseases, Rutgers New Jersey Medical School, Newark, NJ, USA. finkeldi@njms.rutgers.edu.

Zitieren

APA

Alabed, S. T., & Finkel, D. (2026). Ocular TB as the only manifestation of TB: diagnostic uncertainty and treatment thresholds. International Ophthalmology, 46(1). https://doi.org/10.1007/s10792-026-04134-3

Vancouver

Alabed ST, Finkel D. Ocular TB as the only manifestation of TB: diagnostic uncertainty and treatment thresholds. International Ophthalmology. 2026;46(1). doi:10.1007/s10792-026-04134-3

BibTeX
@article{Alabed2026,
  author = {Alabed, Sedra T and Finkel, Diana},
  title = {Ocular TB as the only manifestation of TB: diagnostic uncertainty and treatment thresholds},
  journal = {International Ophthalmology},
  year = {2026},
  volume = {46},
  number = {1},
  doi = {10.1007/s10792-026-04134-3}
}
Kostenlos starten →